Combination of high-frequency electric with 5-ALA photodynamic therapy in cellular angiofibroma of vulva: A case report
•Cellular angiofibroma(CA)is a rare stromal tumor.•Due to the individual differences of patient, we used the high-frequency electric pretreatment combined with 5-Aminolevulinic acid (5-ALA) photodynamic therapy.•And patients were satisfied with the treatment results. Cellular angiofibroma is a rare...
Gespeichert in:
Veröffentlicht in: | Photodiagnosis and photodynamic therapy 2023-06, Vol.42, p.103289, Article 103289 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Cellular angiofibroma(CA)is a rare stromal tumor.•Due to the individual differences of patient, we used the high-frequency electric pretreatment combined with 5-Aminolevulinic acid (5-ALA) photodynamic therapy.•And patients were satisfied with the treatment results.
Cellular angiofibroma is a rare benign tumor and difficult to diagnose. Surgery was used in most cases of prior treatment. However, due to the individual differences, this method may be limited, and there is a risk of recurrence. After signing informed consent for treatment, we treated an 18-year-old female with cellular angiofibroma successfully by using the High-Frequency electric pretreatment combined with 5-Aminolevulinic Acid (5-ALA) photodynamic therapy. The tumor was numerous and irregularly shaped on the right labia majora. The specific treatment process was as follows:5-Aminolevulinic Acid (5-ALA) photodynamic therapy was administered after pretreatment with high-frequency electric ion. We did five treatments in total, 10 days apart. And the therapeutic effect was satisfactory for patients. The wound healed well and no recurrence during 12 months follow-up, and the follow-up is continuing. For similar cases, our experience can be taken into account. |
---|---|
ISSN: | 1572-1000 1873-1597 |
DOI: | 10.1016/j.pdpdt.2023.103289 |